Form 8-K - Current report:
SEC Accession No. 0001493152-25-004554
Filing Date
2025-02-03
Accepted
2025-02-03 06:08:14
Documents
14
Period of Report
2025-01-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57536
2 ex10-1.htm EX-10.1 58928
  Complete submission text file 0001493152-25-004554.txt   309457

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnlx-20250129.xsd EX-101.SCH 3012
4 XBRL LABEL FILE gnlx-20250129_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE gnlx-20250129_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3816
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41599 | Film No.: 25580434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)